Pittsburgh, Pennsylvania 15213


Purpose:

This research will be conducted to determine whether risk factors exist for piperacillin/tazobactam resistance in ESBL organisms.


Study summary:

This is chart review at UPMC. NO human subject interaction will occur.


Criteria:

Inclusion Criteria: - Clinical information is collected by chart review of "case" and "control" patients. - A "case A" patient is defined as follows: One or more clinical cultures are positive for an ESBL producing bacteria and the organism is piperacillin/tazobactam resistant. - A "case B" patient is defined as follows: One or more clinical cultures are positive for an ESBL producing bacteria and the organism is piperacillin/tazobactam susceptible. - Additionally, 1 control patient in the hospital at the same time as the case patients will be randomly selected for each case and are not in either case group. Exclusion Criteria: - Patients < 18 years of age


NCT ID:

NCT00573521


Primary Contact:

Principal Investigator
Brian Potoski, Pharm D
UPMC

Brian Potoski, Pharm D
Phone: 412-648-6401
Email: potoskiba@dom.pitt.edu


Backup Contact:

Email: pakstisdl@dom.pitt.edu
Diana Pakstis, RN, BSN
Phone: 412-648-6553


Location Contact:

Pittsburgh, Pennsylvania 15213
United States

Brian Potoski, Pharm D
Phone: 412-648-6601
Email: potoba@upmc.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.